RETATRUTIDE

Triple-agonist metabolic peptide · 10mg vial

Retatrutide is a triple receptor agonist targeting GIP, GLP-1 and glucagon receptors. It is one of the most studied next-generation metabolic peptides in clinical research, investigated for its effects on body weight and glycemic control.

R 695.00

In stock